Menu
Currency
GWAS Study

Identification of a novel risk locus for multiple sclerosis at 13q31.3 by a pooled genome-wide scan of 500,000 single nucleotide polymorphisms.

Comabella M, Craig DW, Camiña-Tato M et al.

18941528 PubMed ID
GWAS Study Type
2070 Participants
48 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

CM
Comabella M
CD
Craig DW
CM
Camiña-Tato M
MC
Morcillo C
LC
Lopez C
NA
Navarro A
RJ
Rio J
MX
Montalban X
MR
Martin R
Chapter II

Abstract

Summary of the research findings

Multiple sclerosis is a chronic inflammatory demyelinating disease of the central nervous system with an important genetic component and strongest association driven by the HLA genes. We performed a pooling-based genome-wide association study of 500,000 SNPs in order to find new loci associated with the disease. After applying several criteria, 320 SNPs were selected from the microarrays and individually genotyped in a first and independent Spanish Caucasian replication cohort. The 8 most significant SNPs validated in this cohort were also genotyped in a second US Caucasian replication cohort for confirmation. The most significant association was obtained for SNP rs3129934, which neighbors the HLA-DRB/DQA loci and validates our pooling-based strategy. The second strongest association signal was found for SNP rs1327328, which resides in an unannotated region of chromosome 13 but is in linkage disequilibrium with nearby functional elements that may play important roles in disease susceptibility. This region of chromosome 13 has not been previously identified in MS linkage genome screens and represents a novel risk locus for the disease.

242 European ancestry cases, 242 European ancestry controls

Chapter III

Study Statistics

Key metrics and study information

2070
Total Participants
GWAS
Study Type
Yes
Replicated
553 European ancestry cases, 1,033 European ancestry controls
Replication Participants
European
Ancestry
Spain, U.S.
Recruitment Country
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.